Hurley Capital’s Bristol-Myers Squibb BMY Stock Holding History

Hurley Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.24K	Sell	116 -8	-6%	-$506	﹤0.01%	366
2026 Q2	$7.14K	Buy	124 +8	+7%	+$459	﹤0.01%	369
2026 Q1	$7.04K	Sell	116 -107	-48%	-$6.24K	﹤0.01%	368
2025 Q4	$12K	Buy	223 +97	+77%	+$4.67K	0.01%	308
2025 Q3	$5.68K	Buy	126 +10	+9%	+$467	﹤0.01%	426
2025 Q2	$5.37K	Hold	116	–	–	﹤0.01%	363
2025 Q1	$7.08K	Hold	116	–	–	0.01%	355
2024 Q4	$7.13K	Buy	+116	New	+$6.48K	0.01%	314

Other funds holding BMY

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Hurley Capital's BMY Position: Q3 2026 in Review

Hurley Capital reduced its Bristol-Myers Squibb (BMY) stake by 6.5% in Q3 2026, selling an estimated $506 and leaving 116 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Hurley Capital first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $12K in Q4 2025. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Hurley Capital held 116 shares of Bristol-Myers Squibb worth $7.24K as of Q3 2026.
Hurley Capital sold 8 Bristol-Myers Squibb shares in Q3 2026, an estimated $506.
Bristol-Myers Squibb made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #366 holding.
Hurley Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
Hurley Capital's Bristol-Myers Squibb position peaked at $12K in Q4 2025.
1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.